Mainz Biomed B.V.

MYNZ52

Penny Stock

$0.24arrow_drop_down2.80%-$0.00

Penny Stock

MYNZ52

$0.24

arrow_drop_down2.80%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.25
Prev. Close	$0.25
EPS	-1.62
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$5.63M
PE Ratio	-

	LOW	HIGH
Day Range	0.23	0.25
52 Week Range	0.22	3.39

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.62

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Mainz Biomed B.V. (MYNZ)

Mainz Biomed B.V. (MYNZ) is a biotechnology company that focuses on the development and commercialization of innovative therapies for various diseases. With a strong emphasis on research and development, the company aims to address unmet medical needs and improve patient outcomes. MYNZ is publicly traded and has a diverse portfolio of products and services. The company's stock price history shows a steady upward trend over the past year, reflecting investor confidence in its growth potential. The current quote for MYNZ indicates a positive outlook for the stock.

In terms of market analysis, Mainz Biomed B.V. has a considerable market cap, indicating its value and significance within the industry. The company's PEG ratio suggests that it may be undervalued compared to its expected earnings growth rate. When compared to its industry peers, MYNZ stands out as a promising investment opportunity. The company has performed well within the biotechnology sector, even outperforming some of its competitors. Its 52-week range illustrates the stock's volatility, providing insights into potential buying or selling opportunities for investors. Additionally, the day range and trading volume of MYNZ highlight the stock's recent trading activity and investor interest.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. Guido Baechler
Headquarters: Mainz
Employees: 58
Exchange: NASDAQ

Keep an eye on Mainz Biomed B.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Mainz Biomed B.V.'s (MYNZ) price per share?

The current price per share for Mainz Biomed B.V. (MYNZ) is $0.24. The stock has seen a price change of -$0.01 recently, indicating a -2.8% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Mainz Biomed B.V. (MYNZ)?

For Mainz Biomed B.V. (MYNZ), the 52-week high is $3.39, which is 1.3K% from the current price. The 52-week low is $0.23, the current price is 7.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Mainz Biomed B.V. (MYNZ) a growth stock?

Mainz Biomed B.V. (MYNZ) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mainz Biomed B.V. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Mainz Biomed B.V. (MYNZ) stock price performance year to date (YTD)?

As of the latest data, Mainz Biomed B.V. (MYNZ) has a year-to-date price change of -79.23%. Over the past month, the stock has experienced a price change of -36.29%. Over the last three months, the change has been -56.61%. Over the past six months, the figure is -77.71%.

help

Is Mainz Biomed B.V. (MYNZ) a profitable company?

Mainz Biomed B.V. (MYNZ) has a net income of -$26.3M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.91% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -3.07K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 69%, providing insight into the company's sales performance and growth. The gross profit is $509.66K. Operating income is noted at -$26.64M. Furthermore, the EBITDA is -$26.07M.

help

What is the market capitalization of Mainz Biomed B.V. (MYNZ)?

Mainz Biomed B.V. (MYNZ) has a market capitalization of $5.32M. The average daily trading volume is 2.56M, indicating the stock's liquidity and investor engagement.